CELEX: 62019TB0317
Language: en
Date: 2019-11-07 00:00:00
Title: Case T-317/19 R: Order of the President of the General Court of 7 November 2019 — AMVAC Netherlands v Commission (Application for interim measures — Plant protection products — Regulation (EC) No 1107/2009 — Active substance ethoprophos — Conditions for approval for placing the substance on the market — Application for suspension of operation — Lack of urgency)

17.2.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 54/50
            
         
      Order of the President of the General Court of 7 November 2019 — AMVAC Netherlands v Commission
      (Case T-317/19 R)
      (Application for interim measures - Plant protection products - Regulation (EC) No 1107/2009 - Active substance ethoprophos - Conditions for approval for placing the substance on the market - Application for suspension of operation - Lack of urgency)
      (2020/C 54/56)
      Language of the case: English
      
         Parties
      
      
         Applicant: AMVAC Netherlands BV (Amsterdam, Netherlands)) (represented by: C. Mereu, M. Grunchard and S. Englebert, lawyers)
      
         Defendant: European Commission (represented by: F. Castilla-Contreras and I. Naglis, Agents)
      
         Re:
      
      Application pursuant to Articles 278 and 279 TFEU seeking suspension of the operation of Commission Implementing Regulation (EU) 2019/344 of 28 February 2019 concerning the non-renewal of approval of the active substance ethoprophos, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ 2019 L 62, p. 7).
      
         Operative part of the order
      
      
                  1.
               
               
                  
                     The application for interim measures is dismissed.
                  
               
            
                  2.
               
               
                  
                     The costs are reserved.